

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in managing idiopathic pulmonary... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-2052/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-2052" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in managing idiopathic pulmonary fibrosis" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in managing idiopathic pulmonary fibrosis.">
            <meta name="og:description" content="Read the latest article version by Chiara Scelfo, Antonella Caminati, Sergio Harari, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="11560">
            <meta name="article-id" content="10720">
            <meta name="dc.title" content="Recent advances in managing idiopathic pulmonary fibrosis">
            <meta name="dc.description" content="Idiopathic pulmonary fibrosis (IPF) is a rare pulmonary disease with a poor prognosis and severe impact on quality of life. Early diagnosis is still challenging and important delays are registered before final diagnosis can be reached. Available tools fail to predict the variable course of the disease and to evaluate response to antifibrotic drugs. Despite the recent approval of pirfenidone and nintedanib, significant challenges remain to improve prognosis and quality of life. It is hoped that the new insights gained in pathobiology in the last few years will lead to further advances in the diagnosis and management of IPF. Currently, early diagnosis and prompt initiation of treatments reducing lung function loss offer the best hope for improved outcomes. This article aims at providing an overview of recent advances in managing patients with IPF and has a particular focus on how to reach a diagnosis, manage comorbidities and lung transplantation, care for the non-pharmacological needs of patients, and address palliative care.">
            <meta name="dc.subject" content="idiopathic pulmonary fibrosis, pirfenidone, nintedanib, pathogenesis">
            <meta name="dc.creator" content="Scelfo, Chiara">
            <meta name="dc.creator" content="Caminati, Antonella">
            <meta name="dc.creator" content="Harari, Sergio">
            <meta name="dc.date" content="2017/11/27">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.10720.1">
            <meta name="dc.source" content="F1000Research 2017 6:2052">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="idiopathic pulmonary fibrosis">
            <meta name="prism.keyword" content="pirfenidone">
            <meta name="prism.keyword" content="nintedanib">
            <meta name="prism.keyword" content="pathogenesis">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/11/27">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="2052">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.10720.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-2052">
            <meta name="citation_title" content="Recent advances in managing idiopathic pulmonary fibrosis">
            <meta name="citation_abstract" content="Idiopathic pulmonary fibrosis (IPF) is a rare pulmonary disease with a poor prognosis and severe impact on quality of life. Early diagnosis is still challenging and important delays are registered before final diagnosis can be reached. Available tools fail to predict the variable course of the disease and to evaluate response to antifibrotic drugs. Despite the recent approval of pirfenidone and nintedanib, significant challenges remain to improve prognosis and quality of life. It is hoped that the new insights gained in pathobiology in the last few years will lead to further advances in the diagnosis and management of IPF. Currently, early diagnosis and prompt initiation of treatments reducing lung function loss offer the best hope for improved outcomes. This article aims at providing an overview of recent advances in managing patients with IPF and has a particular focus on how to reach a diagnosis, manage comorbidities and lung transplantation, care for the non-pharmacological needs of patients, and address palliative care.">
            <meta name="citation_description" content="Idiopathic pulmonary fibrosis (IPF) is a rare pulmonary disease with a poor prognosis and severe impact on quality of life. Early diagnosis is still challenging and important delays are registered before final diagnosis can be reached. Available tools fail to predict the variable course of the disease and to evaluate response to antifibrotic drugs. Despite the recent approval of pirfenidone and nintedanib, significant challenges remain to improve prognosis and quality of life. It is hoped that the new insights gained in pathobiology in the last few years will lead to further advances in the diagnosis and management of IPF. Currently, early diagnosis and prompt initiation of treatments reducing lung function loss offer the best hope for improved outcomes. This article aims at providing an overview of recent advances in managing patients with IPF and has a particular focus on how to reach a diagnosis, manage comorbidities and lung transplantation, care for the non-pharmacological needs of patients, and address palliative care.">
            <meta name="citation_keywords" content="idiopathic pulmonary fibrosis, pirfenidone, nintedanib, pathogenesis">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Chiara Scelfo">
            <meta name="citation_author_institution" content="Unit&agrave; Operativa di Pneumologia e Terapia Semi-Intensiva Respiratoria, Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare, Ospedale San Giuseppe, Multimedica IRCCS, Milan, Italy">
            <meta name="citation_author" content="Antonella Caminati">
            <meta name="citation_author_institution" content="Unit&agrave; Operativa di Pneumologia e Terapia Semi-Intensiva Respiratoria, Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare, Ospedale San Giuseppe, Multimedica IRCCS, Milan, Italy">
            <meta name="citation_author" content="Sergio Harari">
            <meta name="citation_author_institution" content="Unit&agrave; Operativa di Pneumologia e Terapia Semi-Intensiva Respiratoria, Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare, Ospedale San Giuseppe, Multimedica IRCCS, Milan, Italy">
            <meta name="citation_publication_date" content="2017/11/27">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="2052">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.10720.1">
            <meta name="citation_firstpage" content="2052">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-2052/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-2052.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=11560 /> <input type=hidden id=articleId name=articleId value=10720 /> <input type=hidden id=xmlUrl value="/articles/6-2052/v1/xml"/> <input type=hidden id=xmlFileName value="-6-2052-v1.xml"> <input type=hidden id=article_uuid value=e167d0d2-3e6d-4674-9fa5-c3cca3cfb21b /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in managing idiopathic pulmonary fibrosis"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.10720.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.10720.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-2052"
  },
  "headline": "Recent advances in managing idiopathic pulmonary fibrosis",
  "datePublished": "2017-11-27T16:19:34",
  "dateModified": "2017-11-27T16:19:34",
  "author": [
    {
      "@type": "Person",
      "name": "Chiara Scelfo"
    },    {
      "@type": "Person",
      "name": "Antonella Caminati"
    },    {
      "@type": "Person",
      "name": "Sergio Harari"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Idiopathic pulmonary fibrosis (IPF) is a rare pulmonary disease with a poor prognosis and severe impact on quality of life. Early diagnosis is still challenging and important delays are registered before final diagnosis can be reached. Available tools fail to predict the variable course of the disease and to evaluate response to antifibrotic drugs. Despite the recent approval of pirfenidone and nintedanib, significant challenges remain to improve prognosis and quality of life. It is hoped that the new insights gained in pathobiology in the last few years will lead to further advances in the diagnosis and management of IPF. Currently, early diagnosis and prompt initiation of treatments reducing lung function loss offer the best hope for improved outcomes. This article aims at providing an overview of recent advances in managing patients with IPF and has a particular focus on how to reach a diagnosis, manage comorbidities and lung transplantation, care for the non-pharmacological needs of patients, and address palliative care."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-2052.html",
            "name": "Recent advances in managing idiopathic pulmonary fibrosis"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in managing idiopathic pulmonary fibrosis </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=11560 data-id=10720 data-downloads="" data-views="" data-scholar="10.12688/f1000research.10720.1" data-recommended="" data-doi="10.12688/f1000research.10720.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-2052/v1/pdf?article_uuid=e167d0d2-3e6d-4674-9fa5-c3cca3cfb21b" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-10720-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-10720-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-10720-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Scelfo C, Caminati A and Harari S. Recent advances in managing idiopathic pulmonary fibrosis [version 1; peer review: 4 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2052 (<a class=new-orange href="https://doi.org/10.12688/f1000research.10720.1" target=_blank>https://doi.org/10.12688/f1000research.10720.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-10720-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=10720 id=track-article-signin-10720 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/10720?target=/articles/6-2052.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=11560 /> <input name=articleId type=hidden value=10720 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in managing idiopathic pulmonary fibrosis</h1><span class=other-info> [version 1; peer review: 4 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Chiara Scelfo<a href="https://orcid.org/0000-0002-3192-3882" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-3192-3882</div>,&nbsp;</span><span class=""><a href="mailto:lafitta@libero.it" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Antonella Caminati</span></a><a href="https://orcid.org/0000-0002-6414-3460" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6414-3460</div>,&nbsp;</span><span class="">Sergio Harari</span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Chiara Scelfo<a href="http://orcid.org/0000-0002-3192-3882" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-3192-3882</div>,&nbsp;</span><span class=""><a href="mailto:lafitta@libero.it" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Antonella Caminati</span></a><a href="http://orcid.org/0000-0002-6414-3460" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6414-3460</div>,&nbsp;</span><span class="">Sergio Harari</span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 27 Nov 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.10720.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Unit&agrave; Operativa di Pneumologia e Terapia Semi-Intensiva Respiratoria, Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare, Ospedale San Giuseppe, Multimedica IRCCS, Milan, Italy<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=15286-28183></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=28242-28182></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=7419-28181></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=15287-28184></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Idiopathic pulmonary fibrosis (IPF) is a rare pulmonary disease with a poor prognosis and severe impact on quality of life. Early diagnosis is still challenging and important delays are registered before final diagnosis can be reached. Available tools fail to predict the variable course of the disease and to evaluate response to antifibrotic drugs. Despite the recent approval of pirfenidone and nintedanib, significant challenges remain to improve prognosis and quality of life. It is hoped that the new insights gained in pathobiology in the last few years will lead to further advances in the diagnosis and management of IPF. Currently, early diagnosis and prompt initiation of treatments reducing lung function loss offer the best hope for improved outcomes. This article aims at providing an overview of recent advances in managing patients with IPF and has a particular focus on how to reach a diagnosis, manage comorbidities and lung transplantation, care for the non-pharmacological needs of patients, and address palliative care. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> idiopathic pulmonary fibrosis, pirfenidone, nintedanib, pathogenesis </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Antonella Caminati (<a href="mailto:lafitta@libero.it">lafitta@libero.it</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Antonella Caminati </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Scelfo C <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Scelfo C, Caminati A and Harari S. Recent advances in managing idiopathic pulmonary fibrosis [version 1; peer review: 4 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2052 (<a href="https://doi.org/10.12688/f1000research.10720.1" target=_blank>https://doi.org/10.12688/f1000research.10720.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 27 Nov 2017, <b>6</b>(F1000 Faculty Rev):2052 (<a href="https://doi.org/10.12688/f1000research.10720.1" target=_blank>https://doi.org/10.12688/f1000research.10720.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 27 Nov 2017, <b>6</b>(F1000 Faculty Rev):2052 (<a href="https://doi.org/10.12688/f1000research.10720.1" target=_blank>https://doi.org/10.12688/f1000research.10720.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d17087e168>Introduction</h2><p class="" id=d17087e171>Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing disease of unknown cause limited to the lungs. It is a fatal, age-related lung disease characterized by a mean survival time ranging from 3 to 5 years<sup><a href="#ref-1">1</a></sup>. In Europe and North America, the incidence of IPF is 3–9 cases per 100,000 people and is increasing worldwide<sup><a href="#ref-2">2</a>,<a href="#ref-3">3</a></sup>.</p><p class="" id=d17087e185>Knowledge about IPF pathogenesis is evolving and the currently prevailing hypothesis is that the disease involves a crosstalk between the alveolar epithelium and underlying mesenchyme leading to aberrant wound healing, scarring of the lung, and progressive loss of function<sup><a href="#ref-1">1</a></sup>. Despite recent advances in understanding the disease pathobiology, IPF management remains difficult, particularly because of its unpredictable course with some patients experiencing prolonged periods of slow and progressive decline and others succumbing to acute exacerbations (AEs).</p><p class="" id=d17087e192>This article aims at providing an overview of recent advances in managing patients with IPF and has a particular focus on how to reach a diagnosis, manage comorbidities and lung transplantation, care for the non-pharmacological needs of patients, and address palliative care. As we have known for a long time from the oncology field, patients receiving palliative care need less aggressive care at the end of life (EOL) and have better quality of life. Antifibrotic treatment with pirfenidone and nintedanib was discussed in the March 2014<sup><a href="#ref-4">4</a></sup> and May 2016<sup><a href="#ref-5">5</a></sup> issues of this journal and is not the purpose of this review.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17087e206>Lung transplantation</h2><p class="" id=d17087e209>Lung transplantation is an important option to improve the survival of eligible patients<sup><a href="#ref-6">6</a></sup> and represents a treatment option for patients who fail to respond to medical treatment and progress to an advanced stage of the disease<sup><a href="#ref-7">7</a>,<a href="#ref-8">8</a></sup>. We know that survival after lung transplantation at 5 years is about 50% (47%–53%). Post-transplant survival for interstitial lung disease (ILD) patients is 4.7 years, much lower than for other underlying pre-transplant diseases<sup><a href="#ref-6">6</a></sup> (that is, less than post-transplant survival for patients with chronic obstructive pulmonary disease (COPD) and cystic fibrosis<sup><a href="#ref-9">9</a></sup>). While lung transplantation is the only possible therapy in severe IPF, it may be challenged by several complications: (1) infections and neoplasms in native lung<sup><a href="#ref-7">7</a>,<a href="#ref-8">8</a></sup> (in case of single-lung recipients), (2) extra-pulmonary comorbidities exacerbated by the transplant (that is, heart failure, osteoporosis, and so on)<sup><a href="#ref-7">7</a></sup>, (3) chronic lung allograft dysfunction (CLAD), and (4) recurrence of the disease in the graft, another rare but observed complication<sup><a href="#ref-10">10</a></sup>. CLAD includes both the obstructive pattern (restraining bronchiolitis obliterans syndrome) and less frequently the restrictive pattern<sup><a href="#ref-7">7</a></sup>. Size mismatch is a risk factor for the development of airway complications such as fistula, granulation, bronchomalacia, or strictures. Strictures may occur at the site of surgical anastomosis but may also occur distally, isolated, or as part of the so-called vanishing syndrome<sup><a href="#ref-7">7</a></sup>.</p><p class="" id=d17087e255>Therefore, appropriate selection of lung transplant recipients is an important determinant of outcomes. Since lung transplantation presents a significant risk of perioperative morbidity and mortality, it is important to consider the overall sum of contraindications and comorbidities. In the consensus document for the selection of lung transplant candidates, Weill and colleagues summarized timing of referral and listing, relative and absolute indications, and contraindications for lung transplant<sup><a href="#ref-8">8</a></sup>. In order to ensure the best outcome, the functional status of IPF patients listed for lung transplant should be maintained as best as possible. For this reason, patients should actively participate in a supervised pulmonary rehabilitation programme<sup><a href="#ref-7">7</a></sup>. Although lung transplantation is an effective therapy, less than 20% of patients with IPF receive a lung transplant and this is because of delay in referral to transplant centres and high mortality in transplant list<sup><a href="#ref-11">11</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17087e273>Medical approach to patients with idiopathic pulmonary fibrosis</h2><p class="" id=d17087e276>We have recently acquired two drugs approved for the treatment of IPF—pirfenidone and nintedanib—that have been shown to slow the loss of lung function. However, both drugs have shown little effect in improving patient symptoms. Because of this, quality of life remains an important unmet medical need, as does the treatment approach for more severe cases. Most of the patients with an advanced stage of the disease often fail in understanding and accepting the disease course variability and experience anxiety as the disease relentlessly progresses<sup><a href="#ref-12">12</a></sup>. For these reasons, patients with IPF should be evaluated for eligibility to palliative care in order to manage these symptoms. In addition to symptoms of anxiety about the disease itself, patients with IPF often show associated comorbidities—for example, pulmonary hypertension (PH), gastroesophageal reflux disease (GERD), obstructive sleep apnoea (OSA), COPD, pulmonary embolism, ischaemic heart disease, and lung cancer—which need to be considered and treated and which may significantly modify prognosis.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17087e286>Recent advances in idiopathic pulmonary fibrosis treatment follow progress in pathobiology</h2><p class="" id=d17087e289>Although IPF pathobiology is not yet fully understood, knowledge has substantially improved which has shifted the approach to treatment. In 2000, the American Thoracic Society recommended corticosteroids in addition to cytotoxic agents (cyclophosphamide or azathioprine) on the basis of the hypothesis that inflammation preceded fibrosis<sup><a href="#ref-1">1</a>,<a href="#ref-13">13</a></sup>. Current hypotheses suggest a pattern of abnormal wound-healing responses driven by ongoing alveolar epithelial microinjuries, which induce a fibrotic environment. It is assumed that the growth factors secreted by the injured epithelial cells and macrophages promote fibroblast recruitment, proliferation, and differentiation into myofibroblasts. This results in myofibroblast foci, the histological hallmark of usual interstitial pneumonia (UIP), in which the excessive collagen production leads to scarring of the lung and progressive destruction of the lung architecture, especially in ageing subjects or in those with genetic predisposition<sup><a href="#ref-5">5</a>,<a href="#ref-14">14</a></sup>. Recently, clinical trials have shifted their attention from anti-inflammatory and immunosuppressant drugs to new mechanisms and pathogenetic pathways. Since the 2005 Idiopathic Pulmonary Fibrosis International Group Exploring N-Acetylcysteine I Annual (IFIGENIA) study<sup><a href="#ref-15">15</a></sup>, many clinical trials were published on IPF treatment which used, for instance, interferon gamma-1b (INSPIRE)<sup><a href="#ref-16">16</a></sup>; prednisone, azathioprine, and <i>N</i>-acetylcysteine with an arm using these drugs in combination therapy, an arm with <i>N</i>-acetylcysteine alone, and a placebo group (PANTHER-IPF)<sup><a href="#ref-17">17</a></sup>; endothelin receptor antagonists (bosentan<sup><a href="#ref-18">18</a></sup> and ambrisentan<sup><a href="#ref-19">19</a></sup>); sildenafil, a phosphodiesterase 5 inhibitor<sup><a href="#ref-20">20</a></sup>; warfarin versus placebo<sup><a href="#ref-21">21</a></sup>; imatinib<sup><a href="#ref-22">22</a></sup>; and macitentan<sup><a href="#ref-23">23</a></sup>. However, all trials failed their end points. In addition, the PANTHER-IPF trial showed that treatment with prednisone, azathioprine, and <i>N</i>-acetylcysteine was harmful compared with placebo<sup><a href="#ref-17">17</a></sup>. All trials involved patients with mild to moderate IPF. The only study considering severe IPF—diffusion capacity of the lungs for carbon monoxide of less than 35%—is the one using sildenafil<sup><a href="#ref-20">20</a></sup>. In this double-blind, randomized, placebo-controlled trial, the hypothesis was that treatment with sildenafil would improve walk distance, dyspnoea, and quality of life in patients with advanced IPF. This study did not show a benefit for sildenafil for the primary outcome, which was the proportion of patients with an increase in the 6-minute walk distance (6MWD) of 20% or more. Nevertheless, sildenafil-treated patients have some differences favouring sildenafil in some secondary outcomes, including the degree of dyspnoea and quality of life. In the subsequent sub-analysis from Han and colleagues, the aim was to determine whether sildenafil improves 6MWD in subjects with IPF and right ventricular dysfunction<sup><a href="#ref-24">24</a></sup>. The conclusion was that sildenafil treatment results in better preservation of exercise capacity (a significant difference in 6MWD of 99 metres was observed between patients with and without right ventricular dysfunction) and also improves quality of life<sup><a href="#ref-24">24</a></sup>.</p><p class="" id=d17087e370>Since 2011, a new interest in antifibrosing drugs has appeared. After Japanese studies<sup><a href="#ref-25">25</a>,<a href="#ref-26">26</a></sup> on pirfenidone (a drug suppressing transforming growth factor-beta and tumour necrosis factor-alpha with a complex and, in part, unknown mechanism of action), the first large international randomized controlled studies were published and nintedanib (a tyrosine kinase inhibitor) was investigated<sup><a href="#ref-27">27</a>,<a href="#ref-28">28</a></sup>. Both pirfenidone and nintedanib demonstrated a reduction in IPF progression, measured by the reduction in forced vital capacity (FVC) decrease as the primary end point, which is consistent with a slowing of disease progression<sup><a href="#ref-29">29</a>,<a href="#ref-30">30</a></sup>. Nevertheless, these drugs obtained a conditional recommendation by the 2015 update of the 2011 Clinical Practice Guideline<sup><a href="#ref-31">31</a></sup> (there were no data about patients with more severe IPF and with other comorbidities, and the optimal duration of therapy was unknown). Moreover, Nathan and colleagues found significant differences favouring pirfenidone therapy compared with placebo for treatment-emergent all-cause mortality, IPF-related mortality, and treatment-emergent IPF-related mortality<sup><a href="#ref-32">32</a></sup>. Indeed, scientific knowledge advances faster than what guidelines can keep up with.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17087e405>Management of comorbidities</h2><p class="" id=d17087e408>Patients with IPF often experience comorbidities such as PH, emphysema and COPD, pulmonary infection, lung cancer, GERD, cardiovascular disease (that is, acute coronary disease and deep vein thrombosis), diabetes mellitus, and OSA<sup><a href="#ref-33">33</a>,<a href="#ref-34">34</a></sup>. PH—defined as a mean pulmonary artery pressure of more than 25 mm Hg on right heart catheterization (RHC)—may affect patients at the early stage or during the course of the disease. The prevalence of PH ranges from 8% to 50% depending on the population studied (early or advanced IPF) and on how PH is studied (RHC or echocardiogram). PH causes more severe exertional dyspnoea and increases patient 1-year mortality compared with patients without PH. It is also important to detect other comorbidities that may cause or contribute to PH, such as OSA, congestive heart failure, and pulmonary embolism<sup><a href="#ref-35">35</a>,<a href="#ref-36">36</a></sup>. Currently, medications approved for the treatment of pulmonary arterial hypertension have not shown utility in the treatment of PH associated with IPF<sup><a href="#ref-18">18</a>,<a href="#ref-19">19</a>,<a href="#ref-23">23</a></sup>. In particular, because it seems to worsen the prognosis, the use of ambrisentan is not recommended<sup><a href="#ref-19">19</a>,<a href="#ref-37">37</a>,<a href="#ref-38">38</a></sup>.</p><p class="" id=d17087e445>The incidence of lung cancer ranges from 1% to 48%, and it has been demonstrated that squamous cell carcinoma is the most common cancer type with a significantly worse survival rate<sup><a href="#ref-33">33</a></sup>. Therapeutic possibilities should be considered carefully with a detailed risk-benefit analysis. Since surgery may provoke AEs and postoperative morbidity, surgical intervention should be performed in a selected group of patients. In addition, patients with IPF and lung cancer who are not treated surgically should be carefully treated with chemotherapy, and the indication of chemotherapy or radiotherapy (or both) should be evaluated case by case in terms of cost-benefit to the patient, as the same therapies can lead to AEs<sup><a href="#ref-33">33</a></sup>.</p><p class="" id=d17087e456>GERD prevalence is 87–94% and is thought to be involved in pathogenetic mechanisms and to trigger AEs. The use of proton pump inhibitors (PPIs) remains controversial: on the one hand, Lee and colleagues reported that the use of GERD medication (that is, H<sub>2</sub> blockers or PPIs) in a large cohort of patients with IPF was associated with a lower high-resolution computed tomography (HRCT) fibrosis score and longer survival; on the other hand, PPIs only affect the acidity of the reflux without preventing reflux or microaspiration<sup><a href="#ref-39">39</a></sup>. In addition, a recent study by Kreuter and colleagues found that antacid therapy did not improve outcomes in patients with IPF and that it might potentially be associated with an increased risk of infection in patients with an advanced stage of the disease (FVC &lt; 70%)<sup><a href="#ref-40">40</a></sup>. The use of antacid therapy should be contextualized according to the clinical features of each patient with IPF<sup><a href="#ref-41">41</a></sup>. However, more studies assessing the role of antacid therapy in IPF are needed since neither the efficacy nor the safety of PPIs in IPF can currently be assumed<sup><a href="#ref-42">42</a></sup>.</p><p class="" id=d17087e478>The syndrome of combined pulmonary fibrosis and emphysema (CPFE) is defined by the simultaneous presence of combined emphysema of the upper lobes and fibrosis of the lower lobes on chest computed tomography. It is characterized by sub-normal spirometry with preserved lung volumes, strongly impaired carbon monoxide diffusing capacity of the lung, and hypoxaemia at exercise, high prevalence of PH, and poor survival. Patients with CPFE have a higher frequency of both lung cancer and PH, which worsens their prognosis; there are no currently available therapies for this disease phenotype<sup><a href="#ref-43">43</a>,<a href="#ref-44">44</a></sup>. Smoking is the principal risk factor for both emphysema and fibrosis<sup><a href="#ref-33">33</a></sup>.</p><p class="" id=d17087e493>In conclusion, early identification and appropriate treatment of comorbidities are necessary to minimize their impact on the clinical course of IPF and progression of disease<sup><a href="#ref-45">45</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17087e504>Palliative care and end of life of patients with idiopathic pulmonary fibrosis</h2><p class="" id=d17087e507>Quality of life is compromised by clinical symptoms (cough and dyspnoea) and poor prognosis. Dyspnoea causes social isolation and limitation in daily activities<sup><a href="#ref-46">46</a>,<a href="#ref-47">47</a></sup>. Most of the patients with dyspnoea experience depression and anxiety<sup><a href="#ref-48">48</a></sup>. Patients with IPF have chronic respiratory disease without disease-reversing treatment options and face progressive decline. Although the care needs of patients with IPF and their caretakers are similar to those of patients with cancer, early referral to palliative care for these patients is most often not considered<sup><a href="#ref-49">49</a></sup>.</p><p class="" id=d17087e525>The World Health Organization definition of palliative care is the following: “it is an approach that improves the quality of life of patients and their families facing the problem associated with life-threatening illness, through the prevention and relief of suffering by means of early identification and impeccable assessment and treatment of pain and other problems, physical, psychosocial and spiritual”<sup><a href="#ref-50">50</a></sup>. Originally, palliative care was provided as EOL treatment, but it can also be used and adjusted for every disease stage, and patients with IPF represent a minority group eligible for early referral to palliative care<sup><a href="#ref-3">3</a>,<a href="#ref-51">51</a></sup>. Currently, there is little scientific evidence supporting the use of palliative care in IPF and increasing its use could significantly improve patient quality of life.</p><p class="" id=d17087e539>Lindell and colleagues conducted a retrospective study demonstrating that palliative care access for patients with IPF is marginal (13.7%) and delayed<sup><a href="#ref-49">49</a></sup>. A trial by Higginson and colleagues supports the utility of palliative care in patients with pulmonary but not neoplastic disease<sup><a href="#ref-52">52</a></sup>. This study has some limitations due to its short duration and the small population involved. Less attention is given to IPF patients about their prognosis and referral to intensive care than for patients with metastatic cancer<sup><a href="#ref-53">53</a></sup>, including patients with very severe oxygen-dependent diseases<sup><a href="#ref-54">54</a></sup>. Rajala and colleagues showed that do-not-resuscitate orders and EOL decisions are made late in patients’ lifespan and that life-prolonging therapies are likely to continue until the last days of life<sup><a href="#ref-55">55</a></sup>. Death related to IPF is mainly due to respiratory failure caused by either disease progression or AE. According to a consensus perspective statement published in 2016, AE is “an acute, clinically significant deterioration of unidentifiable cause in a patient with underlying IPF”<sup><a href="#ref-56">56</a></sup>. Other diagnostic criteria are the occurrence of unexplained worsening of dyspnoea within 30 days, chest HRCT with new bilateral ground glass appearance or consolidation, and the exclusion of alternative causes, including pulmonary infection by endotracheal aspirate or bronchoalveolar lavage (BAL). Clinical features of AE are not easily distinguished from those of other infectious diseases (C-reactive protein level increase and pulmonary infiltrates)<sup><a href="#ref-57">57</a></sup> (<a href="#f1">Figure 1</a>). A greater effort should be made (for example, by performing a bronchoscopy with BAL to exclude infectious causes) to reach a diagnosis of certainty before the patient’s condition gets worse. AE is burdened with a high mortality rate. Therapies used are non-invasive ventilation<sup><a href="#ref-58">58</a></sup>, parental fluids, antibiotics, high-dose steroids, and morphine. The use of immunosuppressant drugs is debated<sup><a href="#ref-56">56</a></sup>.</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/11560/f6a007d5-f7d3-492d-9402-5859d4ac3760_figure1.gif"><img alt="f6a007d5-f7d3-492d-9402-5859d4ac3760_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/11560/f6a007d5-f7d3-492d-9402-5859d4ac3760_figure1.gif"></a><div class=caption><h3>Figure 1. Chest computed tomography showing diffuse ground glass during acute exacerbation of idiopathic pulmonary fibrosis.</h3><p id=d17087e592>Bilateral and diffuse radiographic ground glass opacities in a case of acute exacerbation of idiopathic pulmonary fibrosis, <b>a</b>) upper lobes and <b>b</b>) middle-lower lobes involvement.</p></div></div><p class="" id=d17087e606>The most common symptoms experienced in advanced IPF are dyspnoea and cough, which are treated with opioids. Dyspnoea leads to anxiety. Therefore, another important goal to pursue is the treatment of anxiety and depression. These conditions have clinically significant symptoms in up to 30% and 50% of the cases, respectively<sup><a href="#ref-59">59</a></sup>. Depressive symptoms are an important predictor of quality of life<sup><a href="#ref-60">60</a></sup>. Depression and anxiety treatments have not been studied in IPF, and more and more evidence comes from other populations. The symptoms of depression and anxiety may be alleviated with a strategy of supportive care. These interventions include appropriate analgesia, smoking cessation, oral opiates to control cough and dyspnoea, supplemental oxygen, and pulmonary rehabilitation<sup><a href="#ref-59">59</a>,<a href="#ref-61">61</a></sup>. In addition, diminution of the side effects related to antifibrotic medication could improve the anxiety that comes from the chronic illness. Reduced physical activity is common in IPF and other chronic respiratory conditions and is an important predictor of mortality<sup><a href="#ref-62">62</a></sup>. Deconditioning is due to multiple reasons, including exertional dyspnoea and symptoms like dry cough that discourage activities. During exercise, the limitations are multifactorial, but a hallmark clinical sign among patients with IPF is the reduction in oxygen saturation caused by a ventilation/perfusion mismatching, oxygen diffusion limitation, and low mixed venous oxygen content<sup><a href="#ref-63">63</a></sup>. It should be noted that patients completing short-term interventions see improvements in exercise capacity, dyspnoea, and quality of life. Dowman and colleagues recently demonstrated clinically important improvements in the 6-minute walk test (6MWT), general symptoms, and health-related quality of life following exercise<sup><a href="#ref-64">64</a></sup>. Lower baseline 6MWT distance and worse baseline symptoms were associated with greater benefit<sup><a href="#ref-64">64</a></sup>. Future studies are needed to define the optimal format and duration of pulmonary rehabilitation for patients with IPF, but given IPF pathophysiology, clinical course, and the robust data of exercise for health benefits, pulmonary rehabilitation supervised programmes should be recommended as standard care for patients with IPF<sup><a href="#ref-59">59</a>,<a href="#ref-63">63</a></sup>.</p><p class="" id=d17087e648>Using drugs to reduce dyspnoea and cough should be another appropriate strategy to reduce anxiety<sup><a href="#ref-55">55</a></sup>. The opioid morphine is one of the drugs commonly used with a centrally acting pain-relieving effect. It operates by inhibiting the central perception of dyspnoea, which lowers the feelings of anxiety and fear. The local effect on opioid receptors in the respiratory tract lowers the level of sensory input to the perceptual areas, which directly affects the central perceptual processing and thus the total sensation of dyspnoea<sup><a href="#ref-65">65</a></sup>. Kohberg and colleagues showed that the major adverse event was constipation but that respiratory depression, the most feared side effect, was not observed in any of the studies<sup><a href="#ref-65">65</a></sup>. It also seemed that central mechanisms for dyspnoea were more important in IPF than local intra-bronchial mechanisms. Finally, morphine seemed to have an effect both at rest and during exercise.</p><p class="" id=d17087e663>Patients with IPF often spent 15% of their last 6 months of life at the hospital. The majority of them also die there. The most probable reason for this result is the lack of EOL discussions, care plans as well as limited use of palliative care services and home hospice care for non-malignant diseases. These patients need support to deal with their chronic disease and help them face their symptoms. Palliative care would be helpful for psychological support and would bring great comfort to these patients.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17087e669>Invasive diagnostic techniques in idiopathic pulmonary fibrosis: focus on cryobiopsy</h2><p class="" id=d17087e672>Another open issue is the time spent to reach final diagnosis. There is often an important time-lag between the appearance of the symptoms and the final diagnosis. Furthermore, although the radiological pattern of UIP is used in the diagnosis of IPF, not all patients with IPF have a UIP pattern on chest computed tomography scan. The typical radiological UIP pattern requires the presence of sub-pleural basal predominance of reticular abnormality and honeycombing with or without traction bronchiectasis. Based on current guidelines, a definite radiological diagnosis of IPF requires the presence of honeycombing, the more specific feature of UIP<sup><a href="#ref-1">1</a></sup>. HRCT features of honeycombing are clustered cystic air space, usually of comparable diameters (3–10 mm, occasionally larger) in overlap lines, mainly sub-pleural and characterized by thick and well-defined walls<sup><a href="#ref-1">1</a></sup>.</p><p class="" id=d17087e683>In addition, when the radiological picture is not typical, a histological diagnosis should be considered. Histological UIP pattern is characterized by the following four criteria: evidence of marked fibrosis/architectural distortion, honeycombing in a predominantly sub-pleural/paraseptal distribution, presence of patchy bits of lung parenchyma caused by fibrosis, and presence of fibroblast foci<sup><a href="#ref-1">1</a></sup>.</p><p class="" id=d17087e690>However, owing to disease severity, patient comorbidities, or lack of patient consent, the histological confirmation of IPF through an open lung biopsy is often not possible. Therefore, in some reference centres, a new diagnostic procedure has been employed over the last few years, namely cryobiopsy performed through broncoscopy. This procedure yields larger tissue samples than conventional transbronchial biopsy (TBB), which increases the probability of reaching a diagnosis of ILD (either IPF or non-IPF) in selected patients. Regardless of how the histological confirmation is reached, it should be remembered that the diagnosis of IPF requires the presence of an idiopathic UIP pattern and the exclusion of all known causes (connective tissue disease such as rheumatoid arthritis or scleroderma and drugs-related causes)<sup><a href="#ref-1">1</a></sup>.</p><p class="" id=d17087e697>Making a diagnosis of IPF requires a multidisciplinary approach integrating clinical profile, radiological appearance, laboratory data and, when those data are inconclusive, invasive procedures to reach histological findings<sup><a href="#ref-1">1</a></sup>. Pulmonologists have developed several types of procedures ranging from less invasive ones, like BAL and endobronchial biopsy, to more invasive ones, like TBB with conventional forceps or cryoprobes (c-TBB), transbronchial needle aspiration, endobronchial ultrasound, trans-thoracic biopsies (computed or ultrasound-guided), and medical thoracoscopy, including surgical lung biopsy (SLB). Currently, in most patients with IPF, it is thought that a combination of clinical profile, HRCT scan features, and laboratory tests may lead to satisfactory diagnostic results<sup><a href="#ref-66">66</a></sup> (<a href="#f2">Figure 2</a>). Given the new treatment possibilities, it is important to carefully weigh the risks and benefits of the diagnostic tools. Genetic markers—like telomerase reverse transcriptase (TERT) mutations, Mucin 5B (MUC5B) polymorphisms, TOLLIP locus conferring susceptibility, and genes encoding surfactant protein—have been detected in familial and also sporadic cases of IPF<sup><a href="#ref-14">14</a>,<a href="#ref-67">67</a></sup>. These markers are present in small numbers of patients and their use is not yet consolidated. Diagnosis may also be reached by using clinical evolution such as functional decline, laboratory tests, or imaging features changing during follow-up which may clarify or modify the previous diagnosis<sup><a href="#ref-68">68</a></sup>. Although BAL helps in the diagnostic process and allows clinicians to recognize inflammatory patterns narrowing the differential diagnosis and excluding other possible causes of ILD, it is not specific. TBB still has a controversial role: Berbescu and colleagues demonstrated that UIP hallmarks (patchy fibrosis, honeycombing, and fibroblastic foci) may be identified in TBB samples<sup><a href="#ref-69">69</a></sup>. TBB usefulness was confirmed by Tomassetti and colleagues, but the study showed that the predominant histopathological pattern in IPF was the indeterminate pattern<sup><a href="#ref-70">70</a></sup>. Therefore, the indeterminate pattern associated with consistent clinical and radiological findings helped in establishing a final diagnosis of IPF. Because of the small size of the biopsy samples, TBB possesses high specificity but low sensibility. More recently, c-TBB has been introduced to obtain larger samples of lung tissue<sup><a href="#ref-71">71</a></sup>. The samples obtained usually have a size of between 40 and 50 mm<sup>2</sup> and a maximum diameter of between 5 and 7 mm<sup><a href="#ref-71">71</a></sup>. Inter-observer variability in UIP pattern recognition is low because samples are retrieved without crash artefacts and contain peripheral structures of the secondary pulmonary lobules<sup><a href="#ref-72">72</a></sup> (<a href="#f3">Figure 3</a>). In the near future, immunohistochemical analysis with markers such as heat shock protein 27, MUC5B, β-catenin, and fascin may be carried out on these samples and will provide useful information on IPF background<sup><a href="#ref-67">67</a></sup>. The procedure is performed with the aid of fluoroscopy and under deep sedation/general anaesthesia, and patients are intubated with an orotracheal tube or a rigid bronchoscope. Complications are limited and the most common one is pneumothorax (in 8–22% of the cases)<sup><a href="#ref-73">73</a></sup>, especially when biopsies are obtained just beneath the pleura. The 30-day mortality is 1.9%<sup><a href="#ref-73">73</a></sup>, major bleeding is less than 1%, and other complications (air embolism and AE of fibrotic lung disease) are rarer<sup><a href="#ref-74">74</a></sup>. To prevent major bleeding, most bronchoscopists use bronchial blockers (for example, Fogarty balloon)<sup><a href="#ref-72">72</a></sup>. The extent of complications depends on the operator’s confidence and expertise with the procedure. This finding is really relevant compared with the rate and type of complications associated with SLB. SLB can lead to prolonged air leak and persisting pain<sup><a href="#ref-75">75</a></sup>. SLB is also associated with a significant rate of AEs, which eventually lead to a high mortality rate at 90 days<sup><a href="#ref-76">76</a></sup>. Because of this, patient selection is critical, and if patients are carefully selected, morbidity/mortality rates are much lower than in unselected patients<sup><a href="#ref-77">77</a></sup>. The value of c-TBB in combination with BAL profiles might be considered in a multidisciplinary diagnostic discussion and thereby allow SLB to be avoided<sup><a href="#ref-78">78</a></sup>. The problem remains in the interpretation of the histological specimens obtained by cryobiopsy, which requires experienced pathologists. In real life, it would be best to refer the most complex cases in centres with the best skilled professionals.</p><div class="fig panel clearfix"><a name=f2 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/11560/f6a007d5-f7d3-492d-9402-5859d4ac3760_figure2.gif"><img alt="f6a007d5-f7d3-492d-9402-5859d4ac3760_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/11560/f6a007d5-f7d3-492d-9402-5859d4ac3760_figure2.gif"></a><div class=caption><h3>Figure 2. Typical high-resolution computed tomography pattern of usual interstitial pneumonia.</h3><p id=d17087e798> <b>a</b>) patchy, predominantly peripheral, sub-pleural and bibasal reticular abnormalities, traction bronchiectasis and bronchiolectasis, and irregular septal thickening associated with honey combing, <b>b</b>) coronal CT section showing bronchiectasis and bronchiolectasis in the bibasal zones.</p></div></div><div class="fig panel clearfix"><a name=f3 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/11560/f6a007d5-f7d3-492d-9402-5859d4ac3760_figure3.gif"><img alt="f6a007d5-f7d3-492d-9402-5859d4ac3760_figure3.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/11560/f6a007d5-f7d3-492d-9402-5859d4ac3760_figure3.gif"></a><div class=caption><h3>Figure 3. Lung cryobiopsy specimen from a man with a histopathological usual interstitial pneumonia pattern.</h3><p id=d17087e821> <b>a</b>) and <b>b</b>) patchy fibrosing pattern is readily apparent at scanning power microscopy; <b>c</b>) numerous fibroblast foci are also readily identifiable (histological section kindly provided by Alberto Cavazza).</p></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17087e840>Conclusions and perspectives</h2><p class="" id=d17087e843>In the last three years, the major drug regulatory agencies (the European Medicines Agency and the US Food and Drug Administration) approved the use of two important drugs: pirfenidone and nintedanib. However, IPF management remains difficult because of poor prognosis and because available therapies are not a definite cure but only decrease IPF progression. It is therefore a priority to get a diagnosis as soon as possible in order to gain access to current therapeutic options in early disease stage. We also look forward to seeing the results of many ongoing phase II and III clinical studies<sup><a href="#ref-79">79</a></sup> which evaluate combinations of drugs already approved (pirfenidone and nintedanib) or new drugs that act against matrix deposition.</p><p class="" id=d17087e850>There is also a growing need for real-life studies that are proven to be useful in clinical practice. Future methodologies should aim at decreasing the use of SLB and developing semi-invasive or invasive procedures like c-TBB together with new diagnostic measures (biomarkers, genetic features, and lavage microbiome) and a more precise interpretation of HRCT scan<sup><a href="#ref-67">67</a></sup>. Disease progression is unpredictable and most patients often fail to discern disease course variability. For these reasons, a standardized symptom score could be introduced in order to allow clinicians to assess the level of disease progression and refer patients with IPF to early evaluation for palliative care to improve their outcomes and quality of life<sup><a href="#ref-80">80</a></sup>. In recent years, we have seen the development of IPF registries, like the one developed in the US by O’Brien and colleagues<sup><a href="#ref-81">81</a></sup> (IPF-PRO) or the German registry proposed by Behr and colleagues<sup><a href="#ref-82">82</a></sup>, to improve understanding in natural history, its impact on patients and current practices in the diagnosis and care of patients with IPF. Last but not least, these registries will remain a repository of samples for future research.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17087e872>Abbreviations</h2><p class="" id=d17087e875>6MWD, 6-minute walk distance; 6MWT, 6-minute walk test; AE, acute exacerbation; BAL, bronchoalveolar lavage; CLAD, chronic lung allograft dysfunction; COPD, chronic obstructive pulmonary disease; CPFE, combined pulmonary fibrosis and emphysema; c-TBB, cryo-transbronchial biopsy; EOL, end of life; FVC, forced vital capacity; GERD, gastroesophageal reflux disease; HRCT, high-resolution computed tomography; ILD, interstitial lung disease; IPF, idiopathic pulmonary fibrosis; MUC5B, Mucin 5B; OSA, obstructive sleep apnoea; PH, pulmonary hypertension; PPI, proton pump inhibitor; RHC, right heart catheterization; SLB, surgical lung biopsy; TBB, transbronchial biopsy; UIP, usual interstitial pneumonia.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d17087e1 class=n-a></a><h2 class=main-title id=d17344>Competing interests</h2><p class=metadata-entry><a name=d17087e105 class=n-a></a><p id=d17087e106> No competing interests were disclosed.</p></p></div><div class=back-section><a name=d17087e1 class=n-a></a><h2 class=main-title id=d17346>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d17087e882 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d17614>References</h2><div class="section ref-list"><a name=d17087e882 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d17087e889 class=n-a></a>Raghu G, Collard HR, Egan JJ, <i> et al.</i>: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. <i>Am J Respir Crit Care Med.</i> 2011; <b>183</b>(6): 788–824. <a target=xrefwindow id=d17087e900 href="http://www.ncbi.nlm.nih.gov/pubmed/21471066">PubMed Abstract </a> | <a target=xrefwindow id=d17087e903 href="http://dx.doi.org/10.1164/rccm.2009-040GL">Publisher Full Text </a> | <a target=xrefwindow id=d17087e907 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5450933">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725498784"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e916 class=n-a></a>Hutchinson J, Fogarty A, Hubbard R, <i> et al.</i>: Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. <i>Eur Respir J.</i> 2015:<b>46</b>(3): 795–806. <a target=xrefwindow id=d17087e927 href="http://www.ncbi.nlm.nih.gov/pubmed/25976683">PubMed Abstract </a> | <a target=xrefwindow id=d17087e930 href="http://dx.doi.org/10.1183/09031936.00185114">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725498784">F1000 Recommendation</a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d17087e943 class=n-a></a>Harari S, Madotto F, Caminati A, <i> et al.</i>: Epidemiology of idiopathic pulmonary fibrosis in Northern Italy. <i>PLoS One.</i> 2016; <b>11</b>(2): e0147072. <a target=xrefwindow id=d17087e954 href="http://www.ncbi.nlm.nih.gov/pubmed/26841042">PubMed Abstract </a> | <a target=xrefwindow id=d17087e957 href="http://dx.doi.org/10.1371/journal.pone.0147072">Publisher Full Text </a> | <a target=xrefwindow id=d17087e961 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4740484">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d17087e970 class=n-a></a>Woodcock HV, Maher TM: The treatment of idiopathic pulmonary fibrosis. <i>F1000Prime Rep.</i> 2014; <b>6</b>: 16. <a target=xrefwindow id=d17087e978 href="http://www.ncbi.nlm.nih.gov/pubmed/24669297">PubMed Abstract </a> | <a target=xrefwindow id=d17087e981 href="http://dx.doi.org/10.12703/P6-16">Publisher Full Text </a> | <a target=xrefwindow id=d17087e984 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3944742">Free Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d17087e993 class=n-a></a>D’Accord C, Maher TM: Recent advances in understanding idiopathic pulmonary fibrosis [version 1; referees: 2 approved]. <i>F1000 Res.</i> 2016; <b>5</b>: 1–13. pii: F1000 Faculty Rev-1046. <a target=xrefwindow id=d17087e1001 href="http://www.ncbi.nlm.nih.gov/pubmed/27303645">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1004 href="http://dx.doi.org/10.12688/f1000research.8209.1">Publisher Full Text </a> | <a target=xrefwindow id=d17087e1007 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4890320">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718534195"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1017 class=n-a></a>Kistler KD, Nalysnyk L, Rotella P, <i> et al.</i>: Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature. <i>BMC Pulm Med.</i> 2014; <b>14</b>: 139. <a target=xrefwindow id=d17087e1028 href="http://www.ncbi.nlm.nih.gov/pubmed/25127540">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1031 href="http://dx.doi.org/10.1186/1471-2466-14-139">Publisher Full Text </a> | <a target=xrefwindow id=d17087e1035 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4151866">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718534195">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d17087e1048 class=n-a></a>Brown AW, Kaya H, Nathan SD: Lung transplantation in IIP: A review. <i>Respirology.</i> 2016; <b>21</b>(7): 1173–1184. <a target=xrefwindow id=d17087e1056 href="http://www.ncbi.nlm.nih.gov/pubmed/26635297">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1059 href="http://dx.doi.org/10.1111/resp.12691">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732132475"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1068 class=n-a></a>Weill D, Benden C, Corris PA, <i> et al.</i>: A consensus document for the selection of lung transplant candidates: 2014—An update from the pulmonary transplantation council of the international society for heart and lung transplantation. <i>J Heart and Lung Transplant.</i> 2015; <b>34</b>(1): 1–15. <a target=xrefwindow id=d17087e1079 href="http://www.ncbi.nlm.nih.gov/pubmed/25085497">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1082 href="http://dx.doi.org/10.1016/j.healun.2014.06.014">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732132475">F1000 Recommendation</a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d17087e1095 class=n-a></a>Verleden GM, Raghu G, Meyer KC, <i> et al.</i>: A new classification system for chronic lung allograft dysfunction. <i>J Heart and Lung Transplant.</i> 2014; <b>33</b>(2): 127–133. <a target=xrefwindow id=d17087e1106 href="http://www.ncbi.nlm.nih.gov/pubmed/24374027">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1109 href="http://dx.doi.org/10.1016/j.healun.2013.10.022">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d17087e1118 class=n-a></a>Barberis M, Harari S, Tironi A, <i> et al.</i>: Recurrence of primary disease in a single lung transplant recipient. <i>Transplant Proc.</i> 1992; <b>24</b>(6): 2660–2662. <a target=xrefwindow id=d17087e1129 href="http://www.ncbi.nlm.nih.gov/pubmed/1465892">PubMed Abstract </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726930068"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1138 class=n-a></a>Yusen RD, Edwards LB, Dipchand AI, <i> et al.</i>: The registry of the international society for heart and lung transplantation: thirty-third adult lung and heart-lung transplant report-2016; focus theme: primary diagnostic indications for transplant. <i>J Heart Lung Transplant.</i> 2016; <b>35</b>(10): 1170–1184. <a target=xrefwindow id=d17087e1149 href="http://www.ncbi.nlm.nih.gov/pubmed/27772669">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1152 href="http://dx.doi.org/10.1016/j.healun.2016.09.001">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726930068">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718632485"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1166 class=n-a></a>Lindell KO, Liang Z, Hoffman LA, <i> et al.</i>: Palliative care and location of death in decedents with idiopathic pulmonary fibrosis. <i>Chest.</i> 2015; <b>147</b>(2): 423–429. <a target=xrefwindow id=d17087e1177 href="http://www.ncbi.nlm.nih.gov/pubmed/25187973">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1180 href="http://dx.doi.org/10.1378/chest.14-1127">Publisher Full Text </a> | <a target=xrefwindow id=d17087e1184 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4314817">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718632485">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718265918"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1197 class=n-a></a>American Thoracic Society, European Respiratory Society: American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. <i>Am J Respir Crit Care Med.</i> 2002; <b>165</b>(2): 277–304. <a target=xrefwindow id=d17087e1205 href="http://www.ncbi.nlm.nih.gov/pubmed/11790668">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1208 href="http://dx.doi.org/10.1164/ajrccm.165.2.ats01">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718265918">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d17087e1221 class=n-a></a>Harari S, Caminati A: IPF: new insight on pathogenesis and treatment. <i>Allergy.</i> 2010; <b>65</b>(5): 537–553. <a target=xrefwindow id=d17087e1229 href="http://www.ncbi.nlm.nih.gov/pubmed/20121758">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1232 href="http://dx.doi.org/10.1111/j.1398-9995.2009.02305.x">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718265920"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1241 class=n-a></a>Demedts M, Behr J, Buhl R, <i> et al.</i>: High-dose acetylcysteine in idiopathic pulmonary fibrosis. <i>N Engl J Med.</i> 2005; <b>353</b>(21): 2229–2242. <a target=xrefwindow id=d17087e1252 href="http://www.ncbi.nlm.nih.gov/pubmed/16306520">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1255 href="http://dx.doi.org/10.1056/NEJMoa042976">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718265920">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1162867"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1268 class=n-a></a>King TE Jr, Albera C, Bradford WZ, <i> et al.</i>: Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo controlled trial. <i>Lancet.</i> 2009; <b>374</b>(9685): 222–228. <a target=xrefwindow id=d17087e1279 href="http://www.ncbi.nlm.nih.gov/pubmed/19570573">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1282 href="http://dx.doi.org/10.1016/S0140-6736(09)60551-1">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1162867">F1000 Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/716097808"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1295 class=n-a></a>Idiopathic Pulmonary Fibrosis Clinical Research Network, Raghu G, Anstrom KJ, <i> et al.</i>: Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. <i>N Engl J Med.</i> 2012; <b>366</b>(21): 1968–1977. <a target=xrefwindow id=d17087e1306 href="http://www.ncbi.nlm.nih.gov/pubmed/22607134">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1309 href="http://dx.doi.org/10.1056/NEJMoa1113354">Publisher Full Text </a> | <a target=xrefwindow id=d17087e1313 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3422642">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/716097808">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/12474956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1327 class=n-a></a>King TE Jr, Brown KK, Raghu G, <i> et al.</i>: BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. <i>Am J Respir Crit Care Med.</i> 2011; <b>184</b>(1): 92–99. <a target=xrefwindow id=d17087e1338 href="http://www.ncbi.nlm.nih.gov/pubmed/21474646">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1341 href="http://dx.doi.org/10.1164/rccm.201011-1874OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/12474956">F1000 Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d17087e1354 class=n-a></a>Raghu G, Behr J, Brown KK, <i> et al.</i>: Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. <i>Ann Intern Med.</i> 2013; <b>158</b>(9): 641–649. <a target=xrefwindow id=d17087e1365 href="http://www.ncbi.nlm.nih.gov/pubmed/23648946">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1368 href="http://dx.doi.org/10.7326/0003-4819-158-9-201305070-00003">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/4808956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1377 class=n-a></a>Idiopathic Pulmonary Fibrosis Clinical Research Network, Zisman DA, Schwarz M, <i> et al.</i>: A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. <i>N Engl J Med.</i> 2010; <b>363</b>(7): 620–628. <a target=xrefwindow id=d17087e1388 href="http://www.ncbi.nlm.nih.gov/pubmed/20484178">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1391 href="http://dx.doi.org/10.1056/NEJMoa1002110">Publisher Full Text </a> | <a target=xrefwindow id=d17087e1395 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3587293">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/4808956">F1000 Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717951800"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1408 class=n-a></a>Noth I, Anstrom KJ, Calvert SB, <i> et al.</i>: A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis. <i>Am J Respir Crit Care Med.</i> 2012; <b>186</b>(1): 88–95. <a target=xrefwindow id=d17087e1419 href="http://www.ncbi.nlm.nih.gov/pubmed/22561965">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1422 href="http://dx.doi.org/10.1164/rccm.201202-0314OC">Publisher Full Text </a> | <a target=xrefwindow id=d17087e1426 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3400994">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717951800">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/3558960"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1439 class=n-a></a>Daniels CE, Lasky JA, Limper AH, <i> et al.</i>: Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results. <i>Am J Respir Crit Care Med.</i> 2010; <b>181</b>(6): 604–610. <a target=xrefwindow id=d17087e1450 href="http://www.ncbi.nlm.nih.gov/pubmed/20007927">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1453 href="http://dx.doi.org/10.1164/rccm.200906-0964OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/3558960">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d17087e1466 class=n-a></a>Raghu G, Million-Rousseau R, Morganti A, <i> et al.</i>: Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial. <i>Eur Respir J.</i> 2013; <b>42</b>(6): 1622–1632. <a target=xrefwindow id=d17087e1477 href="http://www.ncbi.nlm.nih.gov/pubmed/23682110">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1480 href="http://dx.doi.org/10.1183/09031936.00104612">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d17087e1490 class=n-a></a>Han MK, Bach DS, Hagan PG, <i> et al.</i>: Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction. <i>Chest.</i> 2013; <b>143</b>(6): 1699–1708. <a target=xrefwindow id=d17087e1501 href="http://www.ncbi.nlm.nih.gov/pubmed/23732584">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1504 href="http://dx.doi.org/10.1378/chest.12-1594">Publisher Full Text </a> | <a target=xrefwindow id=d17087e1508 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3673665">Free Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718270310"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1517 class=n-a></a>Azuma A, Nukiwa T, Tsuboi E, <i> et al.</i>: Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. <i>Am J Respir Crit Care Med.</i> 2005; <b>171</b>(9): 1040–1047. <a target=xrefwindow id=d17087e1528 href="http://www.ncbi.nlm.nih.gov/pubmed/15665326">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1531 href="http://dx.doi.org/10.1164/rccm.200404-571OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718270310">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/3599956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1544 class=n-a></a>Taniguchi H, Ebina M, Kondoh Y, <i> et al.</i>: Pirfenidone in idiopathic pulmonary fibrosis. <i>Eur Respir J.</i> 2010; <b>35</b>(4): 821–829. <a target=xrefwindow id=d17087e1555 href="http://www.ncbi.nlm.nih.gov/pubmed/19996196">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1558 href="http://dx.doi.org/10.1183/09031936.00005209">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/3599956">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718270311"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1571 class=n-a></a>Noble PW, Albera C, Bradford WZ, <i> et al.</i>: Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. <i>Lancet.</i> 2011; <b>377</b>(9779): 1760–1769. <a target=xrefwindow id=d17087e1582 href="http://www.ncbi.nlm.nih.gov/pubmed/21571362">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1585 href="http://dx.doi.org/10.1016/S0140-6736(11)60405-4">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718270311">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13340022"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1598 class=n-a></a>Richeldi L, Costabel U, Selman M, <i> et al.</i>: Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. <i>N Engl J Med.</i> 2011; <b>365</b>(12): 1079–87. <a target=xrefwindow id=d17087e1609 href="http://www.ncbi.nlm.nih.gov/pubmed/21992121">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1612 href="http://dx.doi.org/10.1056/NEJMoa1103690">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13340022">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718391829"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1625 class=n-a></a>Richeldi L, du Bois RM, Raghu G, <i> et al.</i>: Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. <i>N Engl J Med.</i> 2014; <b>370</b>(22): 2071–2082. <a target=xrefwindow id=d17087e1636 href="http://www.ncbi.nlm.nih.gov/pubmed/24836310">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1639 href="http://dx.doi.org/10.1056/NEJMoa1402584">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718391829">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718391827"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1653 class=n-a></a>King TE Jr, Bradford WZ, Castro-Bernardini S, <i> et al.</i>: A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. <i>N Engl J Med.</i> 2014; <b>370</b>(22): 2083–2092. <a target=xrefwindow id=d17087e1664 href="http://www.ncbi.nlm.nih.gov/pubmed/24836312">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1667 href="http://dx.doi.org/10.1056/NEJMoa1402582">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718391827">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725637988"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1680 class=n-a></a>Raghu G, Rochwerg B, Zhang Y, <i> et al.</i>: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. <i>Am J Respir Crit Care Med.</i> 2015; <b>192</b>(2): e3–19. <a target=xrefwindow id=d17087e1691 href="http://www.ncbi.nlm.nih.gov/pubmed/26177183">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1694 href="http://dx.doi.org/10.1164/rccm.201506-1063ST">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725637988">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727013202"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1707 class=n-a></a>Nathan SD, Albera C, Bradford WZ, <i> et al.</i>: Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis. <i>Lancet Respir Med.</i> 2017; <b>5</b>(1): 33–41. <a target=xrefwindow id=d17087e1718 href="http://www.ncbi.nlm.nih.gov/pubmed/27876247">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1721 href="http://dx.doi.org/10.1016/S2213-2600(16)30326-5">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727013202">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727384824"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1734 class=n-a></a>Suzuki A, Kondoh Y: The clinical impact of major comorbidities on idiopathic pulmonary fibrosis. <i>Respir Investig.</i> 2017; <b>55</b>(2): 94–103. <a target=xrefwindow id=d17087e1742 href="http://www.ncbi.nlm.nih.gov/pubmed/28274539">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1745 href="http://dx.doi.org/10.1016/j.resinv.2016.11.004">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727384824">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d17087e1758 class=n-a></a>Schiza S, Mermigkis C, Margaritopoulos GA, <i> et al.</i>: Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night. <i>Eur Respir Rev.</i> 2015; <b>24</b>(136): 327–339. <a target=xrefwindow id=d17087e1769 href="http://www.ncbi.nlm.nih.gov/pubmed/26028644">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1772 href="http://dx.doi.org/10.1183/16000617.00009114">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d17087e1781 class=n-a></a>Cerri S, Spagnolo P, Luppi F, <i> et al.</i>: Management of idiopathic pulmonary fibrosis. <i>Clin Chest Med.</i> 2012; <b>33</b>(1): 85–94. <a target=xrefwindow id=d17087e1792 href="http://www.ncbi.nlm.nih.gov/pubmed/22365248">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1795 href="http://dx.doi.org/10.1016/j.ccm.2011.11.005">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727697762"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1805 class=n-a></a>Gille T, Didier M, Boubaya M, <i> et al.</i>: Obstructive sleep apnoea and related comorbidities in incident idiopathic pulmonary fibrosis. <i>Eur Respir J.</i> 2017; <b>49</b>(6): pii: 1601934. <a target=xrefwindow id=d17087e1816 href="http://www.ncbi.nlm.nih.gov/pubmed/28596432">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1819 href="http://dx.doi.org/10.1183/13993003.01934-2016">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727697762">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d17087e1832 class=n-a></a>Caminati A, Cassandro R, Harari S: Pulmonary hypertension in chronic interstitial lung diseases. <i>Eur Respir Rev.</i> 2013; <b>22</b>(129): 292–301. <a target=xrefwindow id=d17087e1840 href="http://www.ncbi.nlm.nih.gov/pubmed/23997057">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1843 href="http://dx.doi.org/10.1183/09059180.00002713">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d17087e1852 class=n-a></a>Harari S, Elia D, Humbert M: Pulmonary hypertension in parenchymal lung diseases: any future for new therapies? <i>Chest.</i> 2017; pii: S0012-3692(17)31077-2. <a target=xrefwindow id=d17087e1857 href="http://www.ncbi.nlm.nih.gov/pubmed/28629920">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1860 href="http://dx.doi.org/10.1016/j.chest.2017.06.008">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/11859956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1869 class=n-a></a>Lee JS, Ryu JH, Elicker BM, <i> et al.</i>: Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. <i>Am J Respir Care Med.</i> 2011; <b>184</b>(12): 1390–1394. <a target=xrefwindow id=d17087e1880 href="http://www.ncbi.nlm.nih.gov/pubmed/21700909">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1883 href="http://dx.doi.org/10.1164/rccm.201101-0138OC">Publisher Full Text </a> | <a target=xrefwindow id=d17087e1887 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3262030">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/11859956">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726268247"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1900 class=n-a></a>Kreuter M, Wuyts W, Renzoni E, <i> et al.</i>: Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis. <i>Lancet Respir Med.</i> 2016; <b>4</b>(5): 381–389. <a target=xrefwindow id=d17087e1911 href="http://www.ncbi.nlm.nih.gov/pubmed/27050871">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1914 href="http://dx.doi.org/10.1016/S2213-2600(16)00067-9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726268247">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727762438"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1927 class=n-a></a>Johannson KA, Strâmbu I, Ravaglia C, <i> et al.</i>: Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers? <i>Lancet Respir Med.</i> 2017; <b>5</b>(7): 591–598. <a target=xrefwindow id=d17087e1938 href="http://www.ncbi.nlm.nih.gov/pubmed/28664861">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1941 href="http://dx.doi.org/10.1016/S2213-2600(17)30219-9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727762438">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d17087e1955 class=n-a></a><a target=xrefwindow id=d17087e1956 href="https://clinicaltrials.gov/ct2/show/NCT02085018?term=gastroesophageal+reflux&amp;cond=IPF&amp;rank=3">https://clinicaltrials.gov/ct2/show/NCT02085018?term=gastroesophageal+reflux&amp;cond=IPF&amp;rank=3</a>. </span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1158665"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e1966 class=n-a></a>Mejia M, Carrillo G, Rojas-Serrano J, <i> et al.</i>: Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. <i>Chest.</i> 2009; <b>136</b>(1): 10–15. <a target=xrefwindow id=d17087e1977 href="http://www.ncbi.nlm.nih.gov/pubmed/19225068">PubMed Abstract </a> | <a target=xrefwindow id=d17087e1980 href="http://dx.doi.org/10.1378/chest.08-2306">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1158665">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d17087e1993 class=n-a></a>Cottin V, Nunes H, Brillet PY, <i> et al.</i>: Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. <i>Eur Respir J.</i> 2005; <b>26</b>(4): 586–593. <a target=xrefwindow id=d17087e2004 href="http://www.ncbi.nlm.nih.gov/pubmed/16204587">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2007 href="http://dx.doi.org/10.1183/09031936.05.00021005">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725823145"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e2016 class=n-a></a>Raghu G, Amatto VC, Behr J, <i> et al.</i>: Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review. <i>Eur Respir J.</i> 2015; <b>46</b>(4): 1113–1130. <a target=xrefwindow id=d17087e2027 href="http://www.ncbi.nlm.nih.gov/pubmed/26424523">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2030 href="http://dx.doi.org/10.1183/13993003.02316-2014">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725823145">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d17087e2043 class=n-a></a>Swigris JJ, Kuschner WG, Jacobs SS, <i> et al.</i>: Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. <i>Thorax.</i> 2005; <b>60</b>(7): 588–594. <a target=xrefwindow id=d17087e2054 href="http://www.ncbi.nlm.nih.gov/pubmed/15994268">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2057 href="http://dx.doi.org/10.1136/thx.2004.035220">Publisher Full Text </a> | <a target=xrefwindow id=d17087e2061 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1747452">Free Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d17087e2070 class=n-a></a>Lubin M, Chen H, Elicker B, <i> et al.</i>: A comparison of health-related quality of life in idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. <i>Chest.</i> 2014; <b>145</b>(6): 1333–1338. <a target=xrefwindow id=d17087e2081 href="http://www.ncbi.nlm.nih.gov/pubmed/24458311">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2084 href="http://dx.doi.org/10.1378/chest.13-1984">Publisher Full Text </a> | <a target=xrefwindow id=d17087e2088 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4042514">Free Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718528990"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e2098 class=n-a></a>Holland AE, Fiore JF Jr, Bell EC, <i> et al.</i>: Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease. <i>Respirology.</i> 2014; <b>19</b>(8): 1215–1221. <a target=xrefwindow id=d17087e2109 href="http://www.ncbi.nlm.nih.gov/pubmed/25112470">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2112 href="http://dx.doi.org/10.1111/resp.12360">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718528990">F1000 Recommendation</a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727014404"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e2125 class=n-a></a>Lindell KO, Kavalieratos D, Gibson KF, <i> et al.</i>: The palliative care needs of patients with idiopathic pulmonary fibrosis: a qualitative study of patients and family caregivers. <i>Heart Lung.</i> 2017; <b>46</b>(1): 24–29. <a target=xrefwindow id=d17087e2136 href="http://www.ncbi.nlm.nih.gov/pubmed/27871724">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2139 href="http://dx.doi.org/10.1016/j.hrtlng.2016.10.002">Publisher Full Text </a> | <a target=xrefwindow id=d17087e2143 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5485906">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727014404">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d17087e2156 class=n-a></a>World Health Organization: WHO definition of alliative care—[Internet]. <a target=xrefwindow id=d17087e2158 href="http://www.who.int/cancer/palliative/definition/en/">Reference Source</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d17087e2167 class=n-a></a>Lanken PN, Terry PB, DeLisser DM, <i> et al.</i>: An Official American Thoracic Society Clinical Policy Statement: palliative care for patients with respiratory diseases and critical illnesses. <i>Am J Respir Crit Care Med.</i> 2008; <b>177</b>(8): 912–927. <a target=xrefwindow id=d17087e2178 href="http://www.ncbi.nlm.nih.gov/pubmed/18390964">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2181 href="http://dx.doi.org/10.1164/rccm.200605-587ST">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725267102"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e2190 class=n-a></a>Higginson IJ, Bausewein C, Reilly CC, <i> et al.</i>: An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. <i>Lancet Respir Med.</i> 2014; <b>2</b>(12): 979–987. <a target=xrefwindow id=d17087e2201 href="http://www.ncbi.nlm.nih.gov/pubmed/25465642">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2204 href="http://dx.doi.org/10.1016/S2213-2600(14)70226-7">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725267102">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726099448"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e2217 class=n-a></a>Brown CE, Engelberg RA, Nielsen EL, <i> et al.</i>: Palliative Care for Patients Dying in the Intensive Care Unit with Chronic Lung Disease Compared with Metastatic Cancer. <i>Ann Am Thorac Soc.</i> 2016; <b>13</b>(5): 684–689. <a target=xrefwindow id=d17087e2228 href="http://www.ncbi.nlm.nih.gov/pubmed/26784137">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2231 href="http://dx.doi.org/10.1513/AnnalsATS.201510-667OC">Publisher Full Text </a> | <a target=xrefwindow id=d17087e2235 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5018894">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726099448">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726142008"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e2249 class=n-a></a>Ahmadi Z, Wysham NG, Lundström S, <i> et al.</i>: End-of-life care in oxygen-dependent ILD compared with lung cancer: a national population-based study. <i>Thorax.</i> 2016; <b>71</b>(6): 510–516. <a target=xrefwindow id=d17087e2260 href="http://www.ncbi.nlm.nih.gov/pubmed/26865603">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2263 href="http://dx.doi.org/10.1136/thoraxjnl-2015-207439">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726142008">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726856328"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e2276 class=n-a></a>Rajala K, Lehto JT, Saarinen M, <i> et al.</i>: End-of-life care of patients with idiopathic pulmonary fibrosis. <i>BMC Palliat Care.</i> 2016; <b>15</b>(1): 85. <a target=xrefwindow id=d17087e2287 href="http://www.ncbi.nlm.nih.gov/pubmed/27729035">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2290 href="http://dx.doi.org/10.1186/s12904-016-0158-8">Publisher Full Text </a> | <a target=xrefwindow id=d17087e2294 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5059981">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726856328">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726421746"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e2307 class=n-a></a>Collard HR, Ryerson CJ, Corte TJ, <i> et al.</i>: Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report. <i>Am J Respir Crit Care Med.</i> 2016; <b>194</b>(3): 265–275. <a target=xrefwindow id=d17087e2318 href="http://www.ncbi.nlm.nih.gov/pubmed/27299520">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2321 href="http://dx.doi.org/10.1164/rccm.201604-0801CI">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726421746">F1000 Recommendation</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d17087e2334 class=n-a></a>Caminati A, Harari S: IPF: New insight in diagnosis and prognosis. <i>Respir Med.</i> 2010; <b>104 Suppl 1</b>: S2–S10. <a target=xrefwindow id=d17087e2342 href="http://www.ncbi.nlm.nih.gov/pubmed/20639137">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2345 href="http://dx.doi.org/10.1016/j.rmed.2010.03.012">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d17087e2354 class=n-a></a>Aliberti S, Messinesi G, Gamberini S, <i> et al.</i>: Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases. <i>BMC Pulm Med.</i> 2014; <b>14</b>: 194. <a target=xrefwindow id=d17087e2365 href="http://www.ncbi.nlm.nih.gov/pubmed/25476922">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2368 href="http://dx.doi.org/10.1186/1471-2466-14-194">Publisher Full Text </a> | <a target=xrefwindow id=d17087e2372 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4269964">Free Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d17087e2381 class=n-a></a>Fulton BG, Ryerson CJ: Managing comorbidities in idiopathic pulmonary fibrosis. <i>Int J Gen Med.</i> 2015; <b>8</b>: 309–318. <a target=xrefwindow id=d17087e2389 href="http://www.ncbi.nlm.nih.gov/pubmed/26451121">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2392 href="http://dx.doi.org/10.2147/IJGM.S74880">Publisher Full Text </a> | <a target=xrefwindow id=d17087e2395 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4590408">Free Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d17087e2405 class=n-a></a>Akhtar AA, Ali MA, Smith RP: Depression in patients with idiopathic pulmonary fibrosis. <i>Chron Respir Dis.</i> 2013; <b>10</b>(3): 127–133. <a target=xrefwindow id=d17087e2413 href="http://www.ncbi.nlm.nih.gov/pubmed/23897928">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2416 href="http://dx.doi.org/10.1177/1479972313493098">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d17087e2425 class=n-a></a>De Vries J, Kessels BL, Drent M: Quality of life of idiopathic pulmonary fibrosis patients. <i>Eur Respir J.</i> 2001; <b>17</b>(5): 954–961. <a target=xrefwindow id=d17087e2433 href="http://www.ncbi.nlm.nih.gov/pubmed/11488332">PubMed Abstract </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d17087e2442 class=n-a></a>Spruit MA, Singh SJ, Garvey C, <i> et al.</i>: An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. <i>Am J Respir Crit Care Med.</i> 2013; <b>188</b>(8): e13–64. <a target=xrefwindow id=d17087e2453 href="http://www.ncbi.nlm.nih.gov/pubmed/24127811">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2456 href="http://dx.doi.org/10.1164/rccm.201309-1634ST">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726506953"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e2465 class=n-a></a>Vainsheilboim B: Exercise training in idiopathic pulmonary fibrosis: is it of benefit? <i>Breathe (Sheff).</i> 2016; <b>12</b>(2): 130–138. <a target=xrefwindow id=d17087e2473 href="http://www.ncbi.nlm.nih.gov/pubmed/27408631">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2476 href="http://dx.doi.org/10.1183/20734735.006916">Publisher Full Text </a> | <a target=xrefwindow id=d17087e2479 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4933618">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726506953">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727317826"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e2492 class=n-a></a>Dowman LM, McDonald CF, Hill CJ, <i> et al.</i>: The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial. <i>Thorax.</i> 2017; <b>72</b>(7): 610–619. <a target=xrefwindow id=d17087e2503 href="http://www.ncbi.nlm.nih.gov/pubmed/28213592">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2506 href="http://dx.doi.org/10.1136/thoraxjnl-2016-208638">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727317826">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726222641"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e2519 class=n-a></a>Kohberg C, Andersen CU, Bendstrup E: Opioids: an unexplored option for treatment of dyspnea in IPF. <i>Eur Clin Respir J.</i> 2016; <b>3</b>: 30629. <a target=xrefwindow id=d17087e2527 href="http://www.ncbi.nlm.nih.gov/pubmed/26969472">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2530 href="http://dx.doi.org/10.3402/ecrj.v3.30629">Publisher Full Text </a> | <a target=xrefwindow id=d17087e2533 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4788766">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726222641">F1000 Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d17087e2547 class=n-a></a>Jacob J, Hansell DM: HRCT of fibrosing lung disease. <i>Respirology.</i> 2015; <b>20</b>(6): 859–872. <a target=xrefwindow id=d17087e2555 href="http://www.ncbi.nlm.nih.gov/pubmed/25900734">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2558 href="http://dx.doi.org/10.1111/resp.12531">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d17087e2567 class=n-a></a>Hambly N, Shimbori C, Klob M: Molecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkers. <i>Respirology.</i> 2015; <b>20</b>(7): 1010–1022. <a target=xrefwindow id=d17087e2575 href="http://www.ncbi.nlm.nih.gov/pubmed/26109466">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2578 href="http://dx.doi.org/10.1111/resp.12569">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d17087e2587 class=n-a></a>Travis WD, Costabel U, Hansell DM, <i> et al.</i>: An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. <i>Am J Respir Crit Care Med.</i> 2013; <b>188</b>(6): 733–748. <a target=xrefwindow id=d17087e2598 href="http://www.ncbi.nlm.nih.gov/pubmed/24032382">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2601 href="http://dx.doi.org/10.1164/rccm.201308-1483ST">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d17087e2610 class=n-a></a>Berbescu EA, Katzenstein AL, Snow JL, <i> et al.</i>: Transbronchial biopsy in usual interstitial pneumonia. <i>Chest.</i> 2006; <b>129</b>(5): 1126–1131. <a target=xrefwindow id=d17087e2621 href="http://www.ncbi.nlm.nih.gov/pubmed/16685001">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2624 href="http://dx.doi.org/10.1378/chest.129.5.1126">Publisher Full Text </a> | <a target=xrefwindow id=d17087e2628 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2094131">Free Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d17087e2637 class=n-a></a>Tomassetti S, Cavazza A, Colby TV, <i> et al.</i>: Transbronchial biopsy is useful in predicting UIP pattern. <i>Respir Res.</i> 2012; <b>13</b>: 96. <a target=xrefwindow id=d17087e2648 href="http://www.ncbi.nlm.nih.gov/pubmed/23107232">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2651 href="http://dx.doi.org/10.1186/1465-9921-13-96">Publisher Full Text </a> | <a target=xrefwindow id=d17087e2655 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3499172">Free Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d17087e2664 class=n-a></a>Casoni GL, Tomassetti S, Cavazza A, <i> et al.</i>: Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases. <i>PLoS One.</i> 2014; <b>9</b>(2): e86716. <a target=xrefwindow id=d17087e2675 href="http://www.ncbi.nlm.nih.gov/pubmed/24586252">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2678 href="http://dx.doi.org/10.1371/journal.pone.0086716">Publisher Full Text </a> | <a target=xrefwindow id=d17087e2682 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3938401">Free Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d17087e2692 class=n-a></a>Poletti V, Ravaglia C, Gurioli C, <i> et al.</i>: Invasive diagnostic techniques in idiopathic interstitial pneumonias. <i>Respirology.</i> 2016; <b>21</b>(1): 44–50. <a target=xrefwindow id=d17087e2703 href="http://www.ncbi.nlm.nih.gov/pubmed/26682637">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2706 href="http://dx.doi.org/10.1111/resp.12694">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732132478"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e2715 class=n-a></a>Hagmeyer L, Theegarten D, Treml M, <i> et al.</i>: Validation of transbronchial cryobiopsy in interstitial lung disease - interim analysis of a prospective trial and critical review of the literature. <i>Sarcoidosis Vasc Diffuse Lung Dis.</i> 2016; <b>33</b>(1): 2–9. <a target=xrefwindow id=d17087e2726 href="http://www.ncbi.nlm.nih.gov/pubmed/27055830">PubMed Abstract </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732132478">F1000 Recommendation</a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730458102"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e2739 class=n-a></a>Ravaglia C, Bonifazi M, Wells AU, <i> et al.</i>: Safety and Diagnostic Yield of Transbronchial Lung Cryobiopsy in Diffuse Parenchymal Lung Diseases: A Comparative Study versus Video-Assisted Thoracoscopic Lung Biopsy and a Systematic Review of the Literature. <i>Respiration.</i> 2016; <b>91</b>(3): 215–227. <a target=xrefwindow id=d17087e2750 href="http://www.ncbi.nlm.nih.gov/pubmed/26926876">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2753 href="http://dx.doi.org/10.1159/000444089">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730458102">F1000 Recommendation</a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725504330"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e2766 class=n-a></a>Han Q, Luo Q, Xie JX, <i> et al.</i>: Diagnostic yield and postoperative mortality associated with surgical lung biopsy for evaluation of interstitial lung diseases: A systematic review and meta-analysis. <i>J Thorac Cardiovasc Surg.</i> 2015; <b>149</b>(5): 1394–401.e1. <a target=xrefwindow id=d17087e2777 href="http://www.ncbi.nlm.nih.gov/pubmed/25648484">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2780 href="http://dx.doi.org/10.1016/j.jtcvs.2014.12.057">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725504330">F1000 Recommendation</a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d17087e2793 class=n-a></a>Kondoh Y, Taniguchi H, Kitaichi M, <i> et al.</i>: Acute exacerbation of interstitial pneumonia following surgical lung biopsy. <i>Respir Med.</i> 2006; <b>100</b>(10): 1753–1759. <a target=xrefwindow id=d17087e2804 href="http://www.ncbi.nlm.nih.gov/pubmed/16584880">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2807 href="http://dx.doi.org/10.1016/j.rmed.2006.02.002">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726000519"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e2816 class=n-a></a>Hutchinson JP, Fogarty AW, McKeever TM, <i> et al.</i>: In-Hospital Mortality after Surgical Lung Biopsy for Interstitial Lung Disease in the United States. 2000 to 2011. <i>Am J Respir Crit Care Med.</i> 2016; <b>193</b>(10): 1161–1167. <a target=xrefwindow id=d17087e2827 href="http://www.ncbi.nlm.nih.gov/pubmed/26646481">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2830 href="http://dx.doi.org/10.1164/rccm.201508-1632OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726000519">F1000 Recommendation</a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725931501"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e2844 class=n-a></a>Tomassetti S, Wells AU, Costabel U, <i> et al.</i>: Bronchoscopic Lung Cryobiopsy Increases Diagnostic Confidence in the Multidisciplinary Diagnosis of Idiopathic Pulmonary Fibrosis. <i>Am J Respir Crit Care Med.</i> 2016; <b>193</b>(7): 745–752. <a target=xrefwindow id=d17087e2855 href="http://www.ncbi.nlm.nih.gov/pubmed/26562389">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2858 href="http://dx.doi.org/10.1164/rccm.201504-0711OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725931501">F1000 Recommendation</a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d17087e2871 class=n-a></a><a target=xrefwindow id=d17087e2872><a target=xrefwindow id=d17087e2872 href="https://clinicaltrials.gov/ct2/results?cond=IPF&amp;term=&amp;cntry1=&amp;state1=&amp;SearchAll=Search+all+studies&amp;recrssimple"> https://clinicaltrials.gov/ct2/results?cond=IPF&amp;term=&amp;cntry1=&amp;state1=&amp;SearchAll=Search+all+studies&amp;recrs</a></a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725693758"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e2881 class=n-a></a>Wells AU, Costabel U, Poletti V, <i> et al.</i>: Challenges in IPF diagnosis, current management and future perspectives. <i>Sarcoidosis Vasc Diffuse Lung Dis.</i> 2015; <b>32 Suppl 1</b>: 28–35. <a target=xrefwindow id=d17087e2892 href="http://www.ncbi.nlm.nih.gov/pubmed/26237442">PubMed Abstract </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725693758">F1000 Recommendation</a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726114863"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e2905 class=n-a></a>O’Brien EC, Durheim MT, Gamerman V, <i> et al.</i>: Rationale for and design of the Idiopathic Pulmonary Fibrosis-PRospective Outcomes (IPF-PRO) registry. <i>BMJ Open Respir Res.</i> 2016; <b>3</b>(1): e000108. <a target=xrefwindow id=d17087e2916 href="http://www.ncbi.nlm.nih.gov/pubmed/26835134">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2919 href="http://dx.doi.org/10.1136/bmjresp-2015-000108">Publisher Full Text </a> | <a target=xrefwindow id=d17087e2923 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4716211">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726114863">F1000 Recommendation</a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725419771"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17087e2936 class=n-a></a>Behr J, Kreuter M, Hoeper MM, <i> et al.</i>: Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry. <i>Eur Respir J.</i> 2015; <b>46</b>(1): 186–96. <a target=xrefwindow id=d17087e2947 href="http://www.ncbi.nlm.nih.gov/pubmed/25837040">PubMed Abstract </a> | <a target=xrefwindow id=d17087e2950 href="http://dx.doi.org/10.1183/09031936.00217614">Publisher Full Text </a> | <a target=xrefwindow id=d17087e2954 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4486374">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725419771">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 27 Nov 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-2052.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-2052.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Unit&agrave; Operativa di Pneumologia e Terapia Semi-Intensiva Respiratoria, Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare, Ospedale San Giuseppe, Multimedica IRCCS, Milan, Italy<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-2052/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 27 Nov 2017, 6:2052 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.10720.1">https://doi.org/10.12688/f1000research.10720.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Scelfo C <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=11560 data-id=10720 data-downloads="" data-views="" data-scholar="10.12688/f1000research.10720.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-2052/v1/pdf?article_uuid=e167d0d2-3e6d-4674-9fa5-c3cca3cfb21b" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.10720.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Scelfo C, Caminati A and Harari S. Recent advances in managing idiopathic pulmonary fibrosis [version 1; peer review: 4 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2052 (<a href="https://doi.org/10.12688/f1000research.10720.1" target=_blank>https://doi.org/10.12688/f1000research.10720.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=10720 id=mobile-track-article-signin-10720 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/10720?target=/articles/6-2052.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=11560 /> <input name=articleId type=hidden value=10720 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Paul W Noble</strong>, Department of Medicine, Cedars Sinai Medical Center, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Paolo Spagnolo</strong>, Section of Respiratory Diseases, Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Italy </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Toby Maher</strong>, Department of Respiratory Medicine, Royal Brompton Hospital, UK </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Simon P Hart</strong>, Centre for Cardiovascular and Metabolic Research, Hull York Medical School, UK </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 27 Nov 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-2052.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-2052.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=15286-28183></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=28242-28182></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=7419-28181></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=15287-28184></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=4><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> <th class="c-report-timeline__headings-version p-article__color--dark">4</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-2052/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>27 Nov 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Paul W Noble</strong>, Department of Medicine, Cedars Sinai Medical Center, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Paolo Spagnolo</strong>, Section of Respiratory Diseases, Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Italy </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Toby Maher</strong>, Department of Respiratory Medicine, Royal Brompton Hospital, UK </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Simon P Hart</strong>, Centre for Cardiovascular and Metabolic Research, Hull York Medical School, UK </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-2052.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-2052/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in managing idiopathic pulmonary...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-2052/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-2052/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-2052/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Scelfo C et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-2052/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-2052",
            templates : {
                twitter : "Recent advances in managing idiopathic pulmonary fibrosis. Scelfo C et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-2052/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in managing idiopathic pulmonary fibrosis", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in managing idiopathic pulmonary fibrosis", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/10720/11560")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "11560");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "28181": 0,
                           "28182": 0,
                           "28183": 0,
                           "28184": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "83d0958b-a1db-4204-b1b2-8233ed6a1cf9";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2052.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2052.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2052.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-2052.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-2052.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>